#Peptides
20 articles tagged with #Peptides
KPV Peptide — Anti-inflammatory Pathway Research
KPV is the three-amino-acid C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). Unlike the parent hormone, KPV doesn't activate melanocortin receptors — it carries the anti-inflammatory effect of alpha-MSH without the pigmentation side. This post walks through the NF-κB pathway dampening, cytokine modulation, and where KPV shows up in gut-barrier and skin-condition research.
GHK-Cu Copper Peptide Mechanism — Research Review
GHK-Cu is the copper-bound form of the tripeptide Gly-His-Lys, originally isolated from human plasma in the 1970s. It's one of the few peptides whose mechanism is dominated by extracellular-matrix remodelling rather than receptor-driven signalling. This post walks through what's actually happening at the molecular level — collagen synthesis upregulation, matrix metalloproteinase modulation, dermal papilla cell stimulation, and the antioxidant axis.
GLOW vs KLOW — Regenerative Peptide Stack Research
GLOW and KLOW are two of the most-cited pre-mixed peptide stacks in regenerative research. Both pair the "Wolverine" repair backbone (BPC-157 + TB-500) with GHK-Cu, but KLOW adds KPV for an extra anti-inflammatory arm. This post compares mechanism, target tissues, and the research questions each stack is best suited to.
Tirzepatide vs Semaglutide — Riset Incretin Ganda vs Tunggal
Tirzepatide dan Semaglutide adalah dua peptide incretin yang paling banyak diteliti, tetapi keduanya menargetkan profil reseptor yang berbeda. Perbandingan langsung ini menjelaskan apa yang ditambahkan aktivasi reseptor GIP ke basis GLP-1, mengapa Tirzepatide adalah GIP-biased, dan bagaimana keduanya dibandingkan dalam aplikasi riset.
Tirzepatide vs Semaglutide — Dual vs Single Incretin Research
Tirzepatide and Semaglutide are the two most-studied incretin research peptides, but they target different receptor profiles. This head-to-head explains what GIP-receptor activation adds to a GLP-1 base, why Tirzepatide is GIP-biased, and how the two compounds compare in research applications.
Retatrutide — Tinjauan Riset Agonis Tripel GLP-1/GIP/Glukagon
Retatrutide adalah agonis tripel pertama untuk reseptor GLP-1, GIP, dan glukagon yang memasuki riset incretin utama. Tinjauan ini membahas mekanismenya — apa yang dikontribusikan setiap lengan reseptor, mengapa aktivasi reseptor glukagon penting, dan bagaimana profil reseptor-tripel dibandingkan dengan senyawa dual-incretin.
Retatrutide — Triple GLP-1/GIP/Glucagon Agonist Research Review
Retatrutide is the first triple agonist of GLP-1, GIP, and glucagon receptors to enter major incretin research. This review walks through its mechanism — what each receptor arm contributes, why glucagon-receptor activation matters, and how the triple-receptor profile compares to dual-incretin compounds.
Riset Incretin GLP-1 — Semaglutide, Tirzepatide, Retatrutide Dibandingkan
Perbandingan farmakologi reseptor untuk tiga peptide incretin riset utama: Semaglutide (agonis GLP-1 tunggal), Tirzepatide (co-agonis ganda GIP/GLP-1), dan Retatrutide (agonis tripel GLP-1/GIP/glukagon). Apa yang ditambahkan setiap reseptor ke profil metabolik.
GLP-1 Incretin Research — Semaglutide, Tirzepatide, Retatrutide Compared
A receptor-pharmacology comparison of the three flagship incretin research peptides: Semaglutide (single GLP-1 agonist), Tirzepatide (dual GIP/GLP-1 co-agonist), and Retatrutide (triple GLP-1/GIP/glucagon agonist). What each receptor adds to the metabolic profile.
BPC-157 Mechanism of Action — Research Review
BPC-157 is one of the most-studied regenerative peptides in research literature. This review walks through its mechanism — VEGFR-2 angiogenesis, nitric oxide pathway modulation, fibroblast migration, and the gut-protective signaling that gave the compound its 'Body Protection Compound' name.
BPC-157 Mekanisme Kerja — Tinjauan Riset
BPC-157 adalah salah satu peptide regeneratif yang paling banyak diteliti dalam literatur riset. Tinjauan ini membahas mekanisme kerjanya — angiogenesis VEGFR-2, modulasi jalur nitrogen oksida, migrasi fibroblast, dan sinyal pelindung gastrointestinal yang menjadi asal nama "Body Protection Compound."
BPC-157 vs TB-500 — Pathway Comparison
BPC-157 and TB-500 are the two most-paired peptides in regenerative research, but they engage tissue repair through very different mechanisms. This comparison breaks down where the two compounds overlap, where they diverge, and why the combination is consistently used together rather than separately.